Loading
Scott Bingham

Scott Bingham

Senior Managing Director, Co-Leader of U.S. Corporate Finance, FTI Consulting

Scott Bingham serves as the Co-Leader of U.S. Corporate Finance and Global Co-Leader of the Transactions practice, overseeing a broad range of pre-deal and post-deal advisory services. Mr. Bingham founded the Transactions practice in 2006 and has nearly tripled the revenue of its North American business over the past five years by building a comprehensive platform of services, including strategy, investment banking, valuations, integrated due diligence (commercial, financial, tax, operational, IT, and compensation and benefits), interim management, human capital advisory, tax advisory, integration support and carve-out support.

 

Mr. Bingham has provided acquisition advisory services to clients for more than 30 years, including the past 20 years at FTI Consulting. Throughout his career, he has advised private equity sponsors and corporate clients across the full deal lifecycle, including target identification, due diligence, contract structuring and negotiations, and transition planning. He has also served as a testifying expert in purchase price dispute matters on behalf of private equity and Fortune 500® companies. Mr. Bingham has also served in numerous post-deal roles, including providing integration support, financial advisory to lenders and interim chief financial officer (“CFO”) support.

Mr. Bingham has also played a leading role in developing FTI Consulting’s Healthcare Integrated Diligence platform, which combines financial and tax due diligence with clinical, compliance and operational assessments.

 

Prior to joining FTI Consulting, Mr. Bingham was a Managing Director in the Advisory practice at PricewaterhouseCoopers (“PwC”), where he helped establish the Atlanta office of the Transaction Services practice and served as Practice Leader for the Healthcare Transaction Consulting practice.

 

Relevant Experience and Awards

  • Supported major clients, including Comvest Partners, Flowers Foods, Goldman Sachs, H.I.G. Capital, among others 
  • Served as a successful testifying expert on several purchase price dispute cases on behalf of private equity and Fortune 500® companies
  • Acted as interim financial advisor and CFO for a distressed pharmaceuticals business; achievements included successfully refinancing the business and tripling EBITDA
  • Top 25 Private Equity Consultants and Leaders, The Consulting Report (2023)

Sessions